Diagnostik og behandling af maturity onset diabetes of the young type 3

Keyphrases

• Maturity-onset Diabetes of the Young 100%
• Sulfonylurea 66%
• Hypoglycemia Risk 33%
• Type 2 Diabetes Mellitus (T2DM) 33%
• Glucagon-like 33%
• Clinical Practice Guidelines 33%
• Hypoglycemia 33%
• Receptor Agonist 33%
• Plasma Glucose 33%
• Need to Evaluate 33%
• A1 Receptor 33%
• Combinational Therapy 33%
• Dipeptidyl peptidase-4 (DPP-4) 33%
• Short-acting 33%
• Monogenic Diabetes 33%
• Type I Diabetes 33%
• Glitazones 33%
• Type 1 Diabetes Mellitus (T1DM) 33%
• Metformin 33%

Medicine and Dentistry

• Maturity Onset Diabetes of the Young 100%
• Hypoglycemia 50%
• Sulfonylurea 50%
• Dipeptidyl Peptidase-4 Inhibitor 25%
• Diabetes 25%
• Insulin Dependent Diabetes Mellitus 25%
• Glucagon-Like Peptide-1 Agonist 25%
• Glycon 25%
• Sodium Glucose Cotransporter 2 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Non Insulin Dependent Diabetes Mellitus 100%
• Hypoglycemia 50%
• Sulfonylurea 50%
• Dipeptidyl Peptidase IV Inhibitor 25%
• Sodium Glucose Cotransporter 2 25%
• Glucagon Like Peptide 1 Receptor Agonist 25%
• Metformin 25%
• Insulin Dependent Diabetes Mellitus 25%